| Literature DB >> 32374663 |
Jadranka Stojanovska1, Mason Runge2, Maryam Ghadimi Mahani3, Paul P Cronin1, Mohamed Sayyouh1, Frank Bogun4, El-Sayed H Ibrahim5.
Abstract
OBJECTIVE. Patients with cardiac implantable electronic devices (CIEDs) require cardiac MRI (CMRI) for a variety of reasons. The purpose of this study is to review and evaluate the value and safety of CMRI for patients with in situ CIEDs. CONCLUSION. Late gadolinium enhancement CMRI is the reference standard for assessing myocardial viability in patients with ventricular tachycardia before ablation of arrhythmogenic substrates. The use of late gadolinium enhancement CMRI for patients with CIEDs is safe as long as an imaging protocol is in place and precaution measures are taken.Entities:
Keywords: cardiac MRI; cardiovascular implantable electronic device; metal artifact reduction ventricular tachycardia; metal device–induced artifact
Year: 2020 PMID: 32374663 DOI: 10.2214/AJR.19.21883
Source DB: PubMed Journal: AJR Am J Roentgenol ISSN: 0361-803X Impact factor: 3.959